Your browser doesn't support javascript.
loading
Effective drug combinations in breast, colon and pancreatic cancer cells.
Jaaks, Patricia; Coker, Elizabeth A; Vis, Daniel J; Edwards, Olivia; Carpenter, Emma F; Leto, Simonetta M; Dwane, Lisa; Sassi, Francesco; Lightfoot, Howard; Barthorpe, Syd; van der Meer, Dieudonne; Yang, Wanjuan; Beck, Alexandra; Mironenko, Tatiana; Hall, Caitlin; Hall, James; Mali, Iman; Richardson, Laura; Tolley, Charlotte; Morris, James; Thomas, Frances; Lleshi, Ermira; Aben, Nanne; Benes, Cyril H; Bertotti, Andrea; Trusolino, Livio; Wessels, Lodewyk; Garnett, Mathew J.
Afiliación
  • Jaaks P; Wellcome Sanger Institute, Cambridge, UK.
  • Coker EA; Wellcome Sanger Institute, Cambridge, UK.
  • Vis DJ; Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Edwards O; Oncode Institute, Amsterdam, The Netherlands.
  • Carpenter EF; Wellcome Sanger Institute, Cambridge, UK.
  • Leto SM; Wellcome Sanger Institute, Cambridge, UK.
  • Dwane L; Candiolo Cancer Institute, FPO-IRCCS, Turin, Italy.
  • Sassi F; Wellcome Sanger Institute, Cambridge, UK.
  • Lightfoot H; Candiolo Cancer Institute, FPO-IRCCS, Turin, Italy.
  • Barthorpe S; Wellcome Sanger Institute, Cambridge, UK.
  • van der Meer D; Wellcome Sanger Institute, Cambridge, UK.
  • Yang W; Wellcome Sanger Institute, Cambridge, UK.
  • Beck A; Wellcome Sanger Institute, Cambridge, UK.
  • Mironenko T; Wellcome Sanger Institute, Cambridge, UK.
  • Hall C; Wellcome Sanger Institute, Cambridge, UK.
  • Hall J; Wellcome Sanger Institute, Cambridge, UK.
  • Mali I; Wellcome Sanger Institute, Cambridge, UK.
  • Richardson L; Wellcome Sanger Institute, Cambridge, UK.
  • Tolley C; Wellcome Sanger Institute, Cambridge, UK.
  • Morris J; Wellcome Sanger Institute, Cambridge, UK.
  • Thomas F; Wellcome Sanger Institute, Cambridge, UK.
  • Lleshi E; Wellcome Sanger Institute, Cambridge, UK.
  • Aben N; Wellcome Sanger Institute, Cambridge, UK.
  • Benes CH; Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Bertotti A; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Trusolino L; Candiolo Cancer Institute, FPO-IRCCS, Turin, Italy.
  • Wessels L; Department of Oncology, University of Torino School of Medicine, Turin, Italy.
  • Garnett MJ; Candiolo Cancer Institute, FPO-IRCCS, Turin, Italy.
Nature ; 603(7899): 166-173, 2022 03.
Article en En | MEDLINE | ID: mdl-35197630
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Neoplasias del Colon / Antineoplásicos Límite: Humans Idioma: En Revista: Nature Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Neoplasias del Colon / Antineoplásicos Límite: Humans Idioma: En Revista: Nature Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido